1,704 results on '"Cuker, A"'
Search Results
2. ADVANCING DIVERSITY AND INCLUSIVITY IN OCEAN SCIENCES BY RE-ENVISIONING OVERLOOKED BARRIERS IN SCIENTIFIC DIVING TRAINING
3. SPOTLIGHT : The ASLO Multicultural Program Pioneers Diversity Efforts in the Aquatic Sciences
4. Utility of Activated Partial Thromboplastin Time Screening in Prospective Living Kidney Donors: A Single Center Cohort Study
5. Cost-effectiveness of iptacopan for paroxysmal nocturnal hemoglobinuria
6. Adeno-associated virus–based gene therapy for hemophilia A and B: a systematic review and meta-analysis
7. Pregnancy loss in individuals with von Willebrand disease and unspecified mucocutaneous bleeding disorders: a multicenter cohort study
8. Comparative effectiveness and safety of rivaroxaban with other oral anticoagulants in older adults with nonvalvular atrial fibrillation: population-based analysis in response to updated Beers Criteria
9. Examining postpartum anticoagulation practices: An international survey of healthcare providers
10. International Society on Thrombosis and Haemostasis clinical practice guideline for treatment of congenital hemophilia A and B based on the Grading of Recommendations Assessment, Development, and Evaluation methodology
11. Anticoagulation for stroke prevention in atrial fibrillation and treatment of venous thromboembolism and portal vein thrombosis in cirrhosis: guidance from the SSC of the ISTH
12. Assessing Direct Oral Anticoagulants in the Clinical Laboratory
13. Confidence score: a data-driven measure for inclusive systematic reviews considering unpublished preprints.
14. Management of Therapeutic-intensity Unfractionated Heparin: A Narrative Review on Critical Points
15. Phase 1 study of GSK3368715, a type I PRMT inhibitor, in patients with advanced solid tumors
16. Early initiation of second-line therapy in primary immune thrombocytopenia: insights from real-world evidence
17. Cost-effectiveness of rapid vs in-house vs send-out ADAMTS13 testing for immune thrombotic thrombocytopenic purpura
18. Defining a metrologically traceable and sustainable calibration hierarchy of international normalized ratio for monitoring of vitamin K antagonist treatment in accordance with International Organization for Standardization (ISO) 17511:2020 standard: communication from the International Federation of Clinical Chemistry and Laboratory Medicine–SSC/ISTH working group on prothrombin time/international normalized ratio standardization
19. Effectiveness and safety of prophylactic anticoagulation among hospitalized patients with inflammatory bowel disease
20. American Society of Hematology living guidelines on use of anticoagulation for thromboprophylaxis for patients with COVID-19: executive summary
21. Overuse of corticosteroids in patients with immune thrombocytopenia (ITP) between 2011 and 2017 in the United States
22. Laboratory Monitoring of Heparin Anticoagulation in Hemodialysis: Rationale and Strategies
23. Influence of participant and reviewer characteristics in application scores for a hematology research training program
24. Updated guidance for efficacy and safety outcomes for clinical trials in venous thromboembolism in children: communication from the ISTH SSC Subcommittee on Pediatric and Neonatal Thrombosis and Hemostasis
25. Adding caplacizumab to standard of care in thrombotic thrombocytopenic purpura: a systematic review and meta-analysis
26. Recommendation on the nomenclature for anticoagulants: updated communication from the International Society on Thrombosis and Haemostasis Scientific and Standardization Commitee on the Control of Anticoagulation
27. Four-factor prothrombin complex concentrate for the treatment of oral factor Xa inhibitor-associated bleeding: a meta-analysis of fixed versus variable dosing
28. Proceedings of the immune thrombocytopenia summit: new concepts in mechanisms, diagnosis, and management
29. PB2625: VAYHIT2: A RANDOMIZED, DOUBLE-BLIND, PHASE III TRIAL OF IANALUMAB VS PLACEBO IN ADDITION TO ELTROMBOPAG IN PATIENTS WITH PRIMARY IMMUNE THROMBOCYTOPENIA (ITP) WHO FAILED FIRST-LINE STEROID TREATMENT
30. PB2552: VAYHIA: A RANDOMIZED, DOUBLE-BLIND, PHASE III TRIAL TO ASSESS THE EFFICACY AND SAFETY OF IANALUMAB VS PLACEBO IN PATIENTS WITH WARM AUTOIMMUNE HEMOLYTIC ANEMIA THAT FAILED ≥1 LINE OF TREATMENT
31. PB2636: VAYHIT1: A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PHASE III TRIAL OF IANALUMAB VERSUS PLACEBO IN ADDITION TO FIRST-LINE CORTICOSTEROIDS IN PATIENTS WITH PRIMARY IMMUNE THROMBOCYTOPENIA (ITP)
32. Thrombopoietin receptor agonist discontinuation rates and reasons among patients with immune thrombocytopenia: a study of administrative claims linked with medical chart review
33. Trends in post-discharge prophylactic anticoagulant use among stroke patients in the United States between 2006 and 2019
34. American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis for patients with COVID-19: March 2022 update on the use of anticoagulation in critically ill patients
35. American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: January 2022 update on the use of therapeutic-intensity anticoagulation in acutely ill patients
36. Comparability of clinical trials and spontaneous reporting data regarding COVID-19 vaccine safety
37. Molecular pathogenesis and heterogeneity in type 3 VWD families in U.S. Zimmerman program
38. ASLO Opportunities for Students and Early Career Professionals in Aquatic Sciences.
39. Prophylactic fresh frozen plasma versus prothrombin complex concentrate for preprocedural management of the coagulopathy of liver disease: A systematic review
40. Postoperative bleeding complications in patients with hemophilia undergoing major orthopedic surgery: A prospective multicenter observational study
41. SARS-CoV-2 vaccination and ITP in patients with de novo or preexisting ITP
42. A geomorphological model of susceptibility to the effect of human interventions for environmental licensing determination (SHIELD)
43. Self-controlled assessment of thromboembolic event (TEE) risk following intravenous immune globulin (IGIV) in the U.S. (2006–2012)
44. American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: July 2021 update on postdischarge thromboprophylaxis
45. Reversing the Eutrophication of the Chesapeake Bay and Its People
46. Instead of Eating Fish: The Health Consequences of Eating Seafood from the Chesapeake Bay Compared to Other Choices
47. Ethics and Economics of Building a Food System to Recover the Health of the Chesapeake Bay and Its People
48. Plastic Pollution and the Chesapeake Bay: The Food System and Beyond
49. Passenger Pigeon and Waterfowl: Flights to Extinction and Not
50. Introduction: Starting the Journey to a Sustainable Ecosystem and Healthy People
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.